COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF HEPATITIS B VIRUS

The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a Hepatitis B Virus gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by Hepatitis B Virus infection using said pharmaceutical composition: and methods for inhibiting the expression of a Hepatitis B Virus gene in a cell..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 07. März Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

CHIN DANIEL [VerfasserIn]
DECKERT JOCHEN [VerfasserIn]
HOSSBACH MARKUS [VerfasserIn]
JOHN MATTHIAS [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C07H: Sugars; derivatives thereof; nucleosides; nucleotid (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-03-07, Last update posted on www.tib.eu: 2024-01-01, Last updated: 2024-01-05

Patentnummer:

CA3064103

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA016601246